Search this site
StellaDX.com
  • Home
  • Team
    • Principal Investigators
    • Board of Directors
    • Clinical Advisory Board
  • Investors
    • Investor Deck and News
    • Press Releases
  • Contact
StellaDX.com
  • Home
  • Team
    • Principal Investigators
    • Board of Directors
    • Clinical Advisory Board
  • Investors
    • Investor Deck and News
    • Press Releases
  • Contact
  • More
    • Home
    • Team
      • Principal Investigators
      • Board of Directors
      • Clinical Advisory Board
    • Investors
      • Investor Deck and News
      • Press Releases
    • Contact

Press Releases

Stella Diagnostics Announces Key Additions to its Board of Directors (Feb 24th, 2021)


Stella Diagnostics and Mayo Clinic Enter Into Collaborative Research Agreement (Feb 17th, 2021)


Stella Diagnostics Announces Partnership with mProbe Laboratories (Feb 4th, 2021)


Stella Diagnostics to Present at 23rd Annual ICR Conference (Jan 7th, 2021)


Stella Diagnostics CEO Joe Abdo Featured on Global Cancer Advocacy Podcast 'Out of Patients with Matthew Zachary' (Nov 5th, 2020)


Stella Diagnostics to Present Data on Discovery of Proteomic Chemoresistance Network in Esophageal Cancer Tissue (Oct 22nd, 2020).

Stella Diagnostics to Participate in BIO Investor Forum Digital (Oct 9th, 2020).

Stella Diagnostics Selected as Buzz of BIO Winner for the 2020 BIO Investor Forum Digital (Sept 23rd, 2020).


JMD Properties, Inc. Acquires Diagnostic Oncology Company, Changes Focus to Biotech (Sept 2nd, 2020)


Keystone Capital Partners Announces Founding Investment in Stella Diagnostics (Sept 1st, 2020)


Stella Diagnostics, Inc. | 50 West Broadway, Suite 300 | Salt Lake City, UT 84104 | info@stelladx.com

Report abuse
Page details
Page updated
Report abuse